Nachum Kaplan

988 citations

21 papers · 724 indexed · h-index 16

Co-authors: Eugene Rosenberg Barry Hafkin Zinaida Zosim Molly B. Schmid Brian S. Murphy Daryl J. Hoban Judd Berman Henry W. Pauls
Topics: Antimicrobial Resistance in Staphylococcus (11 papers)Bacterial biofilms and quorum sensing (7 papers)Antibiotic Resistance in Bacteria (7 papers)
Cited by: Molecular Medicine Microbiology Applied Microbiology and Biotechnology
Journals: Applied and Environmental Microbiology Antimicrobial Agents and Chemotherapy European Journal of Biochemistry
Partner nations: United States Israel Canada

In The Last Decade

Nachum Kaplan

21 papers receiving 673 citations

Peers

Countries citing papers authored by Nachum Kaplan

Since Specialization

Citations

This map shows the geographic impact of Nachum Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nachum Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nachum Kaplan more than expected).

Fields of papers citing papers by Nachum Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nachum Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nachum Kaplan. The network helps show where Nachum Kaplan may publish in the future.

Co-authorship network of co-authors of Nachum Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Nachum Kaplan. A scholar is included among the top collaborators of Nachum Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nachum Kaplan. Nachum Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety, tolerability and pharmacokinetics of multiple oral doses of AFN-1252 administered as immediate release (IR) tablets in healthy subjects 2015 ·Journal of Chemotherapy ·Thomas L. Hunt,Nachum Kaplan,Barry Hafkin	9
2	Activity of Debio1452, a FabI Inhibitor with Potent Activity against Staphylococcus aureus and Coagulase-Negative Staphylococcus spp., Including Multidrug-Resistant Strains 2015 ·Antimicrobial Agents and Chemotherapy ·Robert K. Flamm,Paul R. Rhomberg,Nachum Kaplan,Ronald N. Jones,David J. Farrell	25
3	Safety, Tolerability and Pharmacokinetics of AFN–1252 Administered as Immediate Release Tablets in Healthy Subjects 2015 ·Future Microbiology ·Barry Hafkin,Nachum Kaplan,Thomas L. Hunt	13
4	Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities 2015 ·Antimicrobial Agents and Chemotherapy ·Barry Hafkin,Nachum Kaplan,Brian S. Murphy	41
5	Single-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a FabI Inhibitor, the Prodrug Debio 1450 and Its Active Moiety Debio 1452, Administered Intravenously in Healthy Subjects 2015 ·Open Forum Infectious Diseases ·Barry Hafkin,Jolene Kay Berg,Nachum Kaplan,(unknown),Annick Ménétrey,Harry Alcorn,Frederick Wittke	3
6	Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model 2013 ·Journal of Chemotherapy ·Mary Anné Banevicius,Nachum Kaplan,Barry Hafkin,David P. Nicolau	37
7	AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects 2013 ·European Journal of Pharmaceutical Sciences ·Nachum Kaplan,Colin Garner,Barry Hafkin	27
8	In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics 2013 ·Journal of Chemotherapy ·Nachum Kaplan,Donald E. Awrey,(unknown),Judd Berman,Jeremy A. Yethon,Henry W. Pauls,Barry Hafkin	29
9	Perturbation of Staphylococcus aureus Gene Expression by the Enoyl-Acyl Carrier Protein Reductase Inhibitor AFN-1252 2013 ·Antimicrobial Agents and Chemotherapy ·Joshua B. Parsons,(unknown),Pamela Jackson,Mark Pulse,Jerry W. Simecka,(unknown),Jason Weiss,Nachum Kaplan,Charles O. Rock	29
10	Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor 2012 ·Antimicrobial Agents and Chemotherapy ·Nachum Kaplan,Monique Albert,Donald E. Awrey,(unknown),Judd Berman,Teresa E. Clarke,(unknown),Barry Hafkin,(unknown),V. Romanov,Molly B. Schmid,(unknown),Jeremy A. Yethon,Henry W. Pauls	92
11	Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Peter B. Sampson,Christine J. Picard,(unknown),(unknown),(unknown),Andrew Leeson,V. Romanov,Donald E. Awrey,(unknown),(unknown),Nachum Kaplan,Judd Berman,Henry W. Pauls	17
12	AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity 2009 ·Antimicrobial Agents and Chemotherapy ·James A. Karlowsky,Nachum Kaplan,Barry Hafkin,Daryl J. Hoban,George G. Zhanel	66
13	2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI 2009 ·Bioorganic & Medicinal Chemistry Letters ·Jailall Ramnauth,(unknown),Peter B. Sampson,(unknown),(unknown),Emily Freeman,David D. Manning,Fernando A. Martín,András Toró,(unknown),Donald E. Awrey,(unknown),Nachum Kaplan,Judd Berman,Henry W. Pauls	19
14	Use of thermonuclease testing to identify Staphylococcus aureus by direct examination of blood cultures 2003 ·Eastern Mediterranean Health Journal ·Nachum Kaplan	3
15	Microbiology of wound infection after caesarean section in a Jordanian hospital 2003 ·Eastern Mediterranean Health Journal ·Nachum Kaplan,(unknown),(unknown),(unknown)	16
16	DNA fromSerratia marcescensconfers a hydrophobic character inEscherichia coli 1995 ·FEMS Microbiology Letters ·(unknown),Mel Rosenberg,R.J. Doyle,Nachum Kaplan	2
17	Reconstitution of emulsifying activity of Acinetobacter calcoaceticus BD4 emulsan by using pure polysaccharide and protein 1987 ·Applied and Environmental Microbiology ·Nachum Kaplan,Zinaida Zosim,Eugene Rosenberg	69
18	Structural studies of the capsular polysaccharide of Acinetobacter calcoaceticus BD4 1985 ·European Journal of Biochemistry ·Nachum Kaplan,Eugene Rosenberg,Barbara Jann,Klaus Jann	46
19	Capsular polysaccharides interfere with adherence ofAcinetobacter calcoaceticusto hydrocarbon 1983 ·FEMS Microbiology Letters ·Eugene Rosenberg,Nachum Kaplan,Ophry Pines,Mel Rosenberg,David L. Gutnick	59
20	Exopolysaccharide Distribution of and Bioemulsifier Production by Acinetobacter calcoaceticus BD4 and BD413 1982 ·Applied and Environmental Microbiology ·Nachum Kaplan,Eugene Rosenberg	101

About Nachum Kaplan

Nachum Kaplan is a scholar working on Molecular Medicine, Microbiology and Infectious Diseases, having authored 21 papers that have together received 724 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (11 papers), Bacterial biofilms and quorum sensing (7 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Molecular Medicine (236 citations), Microbiology (90 citations) and Applied Microbiology and Biotechnology (29 citations). Nachum Kaplan has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Eugene Rosenberg, Barry Hafkin, Zinaida Zosim, Molly B. Schmid, Brian S. Murphy, Daryl J. Hoban, Judd Berman, Henry W. Pauls, George G. Zhanel and Donald E. Awrey. Their work appears in journals such as Applied and Environmental Microbiology, Antimicrobial Agents and Chemotherapy and European Journal of Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact